Published through 2026-11-03 01:51 UTC · Automated cloud publishing.
Mister Spex Confirms 2024 Guidance Amid Restructuring and Governance Updates
Understand the event
Mister Spex SE has released preliminary unaudited figures for full-year 2024, confirming net revenue declined by 3% to approximately €216 million. This result falls within the company’s guidance range of €210–€230 million and aligns with earlier reporting that attributed the top-line decrease primarily to the closure of international retail locations in Scandinavia, Austria, and Switzerland under the "SpexFocus" restructuring initiative. Despite the overall decline, Mister Spex highlighted a 2% like-for-like growth rate in its core German market and noted improved gross margins, indicating operational efficiency gains amidst portfolio adjustments. Earlier reporting detailed quarterly performance, showing Q3 2024 revenue of €57.8 million (a 3% year-on-year decline) and first-half 2024 net revenue of €119 million with 1% growth. The "SpexFocus" program, designed to increase EBITDA by over €20 million through 2025, remains central to the strategy, balancing international exits with domestic growth. On the governance front, shareholders at the Extraordinary General Meeting on September 20, 2024, approved all management proposals, including the reduction of the Supervisory Board from seven to five members to streamline decision-making. These updates confirm the execution of previously announced resolutions and provide a consolidated view of the company's financial trajectory following significant structural changes.
AI-generated from reporting · updated 24 days ago
Developments
- 10-9 23:25 · 1 reportsMister Spex reports Q1 2024 revenue growthMister Spex:Mister Spex Reports 2% Group Revenue Growth and 5% in Germany for Q1 2024
- 10-9 23:25 · 1 reportsMister Spex announces restructuring program and updates guidMister Spex:Mister Spex Announces 'SpexFocus' Restructuring Program, Closes International Stores, and Updates 2024 Guidance
- 10-9 23:25 · 1 reportsMister Spex reports H1 2024 financial resultsMister Spex:Mister Spex Reports H1 2024 Financial Results with 4% Like-for-Like Growth in Germany
- 10-9 23:25 · 1 reportsMister Spex EGM approves board reduction and resolutionsMister Spex:Mister Spex Shareholders Approve Supervisory Board Reduction and Confirm June Resolutions
- 10-9 23:25 · 1 reportsMister Spex reports Q3 2024 results and confirms guidanceMister Spex:Mister Spex Reports 2% Growth in Core German Market and Improved Gross Margin in Q3 2024 Amid International Store Closures
- 10-9 23:25 · 1 reportsMister Spex reports 2024 financial results and confirms guidMister Spex:Mister Spex Confirms 2024 Guidance with 2% Like-for-Like Growth in German Core Market
Reporting timeline
Follow the reporting for different perspectives.
- Mister SpexMister Spex Reports 2% Group Revenue Growth and 5% in Germany for Q1 2024
Mister Spex SE reported net sales of €51.1 million for the first quarter of 2024, representing a 2% year-on-year increase for the Group. Germany drove this performance with 5% growth, fueled by double-digit gains in sunglasses (11%) and contact lenses (14%), while prescription glasses remained flat. Conversely, the International segment declined by 8%, primarily due to weaker results in Scandinavia, Switzerland, and the UK. Management attributed mixed category outcomes to calendar effects from an earlier Easter and favorable weather conditions boosting outdoor product demand. Adjusted EBITDA remained roughly flat at -3.2% of revenues. The company reconfirmed its fiscal year 2024 guidance, anticipating low-to-mid single-digit revenue growth and a positive adjusted EBITDA margin.
- Mister SpexSelectedMister Spex Announces 'SpexFocus' Restructuring Program, Closes International Stores, and Updates 2024 Guidance
Mister Spex SE has approved the "SpexFocus" transformation and restructuring program for 2024–2025, aiming to increase EBITDA by over €20 million. Key measures include closing all eight international stores (five in Austria, two in Sweden, one in Switzerland) due to lack of profitable growth paths, reducing personnel costs, and repositioning the brand to focus on optician expertise for the 40–60 age demographic. The company also plans to reduce promotional activities and switch its key financial indicator from Adjusted EBITDA to EBIT starting in 2025. Preliminary H1 2024 results showed net revenue of €119 million (+1% YoY) but negative adjusted EBITDA of €-0.8 million, attributed partly to adverse weather affecting sunglasses sales. Consequently, Mister Spex lowered its full-year 2024 guidance to net revenue between €210–€230 million and an adjusted EBITDA margin between +1% and -4%.
- Mister SpexSelectedMister Spex Reports H1 2024 Financial Results with 4% Like-for-Like Growth in Germany
Mister Spex SE reported net revenue of €119 million for the first half of 2024, reflecting a 1% year-on-year growth. In Q2 2024, sales reached €67.6 million, also up 1%. The German market demonstrated robust performance with a 4% like-for-like growth in physical retail during Q2. Prescription glasses sales in Germany rose by 11%, while sunglasses decreased by 2% due to weather conditions. Adjusted EBITDA declined slightly by €0.8 million in H1, though Q2 saw a €0.8 million improvement. The company has initiated its 'SpexFocus' restructuring program targeting over €20 million in EBITDA savings by 2025-2026, alongside a rebranding effort and the launch of a new sports eyewear collection. Active customers fell by 2% to 1.697 million, but average order value increased by 3% to €97.6. Full-year guidance projects net revenue between €210-230 million.
- Mister SpexMister Spex Shareholders Approve Supervisory Board Reduction and Confirm June Resolutions
At its Extraordinary General Meeting on September 20, 2024, Mister Spex SE shareholders approved all management proposals. The vote confirmed the reduction of the Supervisory Board from seven to five members to streamline governance and cut costs under the "SpexFocus" restructuring program. Additionally, resolutions originally passed at the Annual General Meeting on June 7, 2024, were reaffirmed after a shareholder challenge necessitated legal confirmation. Counterproposals were rejected by over 75% of votes cast, while participation exceeded 70% of share capital. Chairman Stephan Schulz-Gohritz outlined updated full-year guidance and highlighted initiatives including personnel cost reductions and the introduction of the SpexPro private label in the premium lens segment.
- Mister SpexSelectedMister Spex Reports 2% Growth in Core German Market and Improved Gross Margin in Q3 2024 Amid International Store Closures
Mister Spex SE reported €57.8 million in revenue for Q3 2024, a 3% year-on-year decline primarily driven by the closure of international stores in Scandinavia, Austria, and Switzerland under its "SpexFocus" restructuring program. Despite the overall drop, the core German market grew by 2%, with prescription glasses revenue rising 4% globally and 5% in Germany. The company achieved a significant gross margin improvement of 302 basis points to 48.8%, attributed to a higher share of high-margin products like the new "SpexPro" premium lens private label and reduced promotional discounts. Average order value increased by 3% to €99.4. Adjusted EBITDA fell to -€1.4 million from €0.2 million in the prior year. Mister Spex confirmed its full-year guidance of €210–€230 million net revenue.
- Mister SpexSelectedMister Spex Confirms 2024 Guidance with 2% Like-for-Like Growth in German Core Market
Mister Spex reported preliminary unaudited figures for 2024, confirming net revenue declined by 3% to approximately €216 million, within its guidance range of €210–€230 million. This decline was primarily driven by the closure of all international stores in the fourth quarter as part of the SpexFocus transformation program. Despite this, the core German market achieved 2% like-for-like growth, with brick-and-mortar stability offsetting broader declines. Adjusted EBITDA turned negative but remained within the guided range of +1% to -4%. Average order value for prescription glasses rose 12% year-over-year, aided by the September launch of the SpexPro lens portfolio. Cash balance exceeded €70 million at year-end. Audited results and 2025 outlook will be published on March 27, 2025.